Bellway PLC (BWY)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 2,180.00 |
|---|---|
| 52-week range | 1,715.00 – 2,890.00 |
| Return, 1 month / 3 months | +5.2% / +12.4% |
| Return, 1 year / 3 years | −17.9% / +17.9% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 39.4% |
| Worst drawdown (1 year) | -39.5% |
| Average daily value traded | 1,035.98M GBX |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bellway PLC is a British housebuilder based in Newcastle upon Tyne. It designs and constructs new homes for private buyers, offering a range of houses and apartments across developments in England, Scotland and Wales. The company also provides affordable housing through its partnerships with housing associations and local authorities. Its customers are mainly individual homebuyers and public bodies seeking new residential properties, and it manages the land buying, construction and sales process for its schemes.
The shares are listed on the London Exchange in UK under the code BWY, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bellway PLC (BWY) trades on the London Exchange in UK. It last closed at GBX 2,180.00 on 23 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,618 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.9% and over the last three months it rose 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.3% | ||
| From 52-week high | -24.0% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.4% | ||
| 6-month return | 11.9% | ||
| 12-month return, skipping the last month | -22.0% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.5% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 1,035.98M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | +5.2% |
| 3 months | +12.4% |
| 6 months | +11.9% |
| 1 year | −17.9% |
| 3 years | +17.9% |
| 5 years | −14.9% |
Signals
| 50-day / 200-day average | 2,090.94 / 2,130.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 74.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Dec 2026 | GBP 0.5200 |
| 21 May 2026 | GBP 0.2300 |
| 4 Dec 2025 | GBP 0.4900 |
| 22 May 2025 | GBP 0.2100 |
| 28 Nov 2024 | GBP 0.3800 |
| 23 May 2024 | GBP 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.